Thus, obesity may attenuate depression treatment responses through induced inflammatory cytokines that alter Akt and GSK3β activity, resulting in changes in several key neurotransmitters. This evidence concerns the gene AKT1 and obesity due to melanocortin 4 receptor deficiency.